BioMarCare develops diagnostic kits based on novel biomarkers for early cancer identification, monitoring and assistance, and to support personalized drug treatment via a simple blood test or standard biopsy. Its products currently in development target breast and colon cancer. The company intends to use newly raised capital for research and development of these kits. BioMarCare is a portfolio company of Hadasit Bio-Holdings Ltd. The company is managed by Mrs. Dana Cohen and its CMO is Prof. Tamar Peretz. Its intellectual property is based on work by doctors and researchers at Hadassah Hospital.

Total raised

$1M

Funding rounds

1

Latest round

Equity

Latest activity

Mar 2012